Antibody drug may cut Covid-19 hospitalizations, company says

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 86%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

Antibody drug may cut Covid-19 hospitalizations, company says.

They are being tested to treat newly diagnosed Covid-19 patients in hope of preventing serious disease or death, and to try to prevent infection in people at high risk of that such as nursing home residents and health workers.

The company felt that giving the actual numbers"told the story in the most balanced way,” said Lilly’s chief scientific officer, Dr. Daniel Skovronsky. The study will continue to test the antibody drug in combination with another from a Chinese company, Junshi Biosciences.also are underway, including two sponsored by the U.S. National Institutes of Health.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

Watch 'Heated Vaccine Debate - Kennedy Jr. vs Dershowitz' on YouTube

TRUST THE SCIENCE. LISTEN TO THE EXPERTS.

In 2008, Michael Greger, MD, physician,internationally recognized expert on public health issues discussed worst pandemics in history, and how to treat the cause by preventing the emergence of pandemic viruses in the first place.

Incredible.

There's various nano antibody efforts and the best really deserve support/coverage

Saying is easy doing is hard and can be confirmed in a transparent society

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 10. in SE

Sverige Senaste nytt, Sverige Rubriker